AN2 Therapeutics, Inc. — All Filings
346 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| D | — | 0001880438-26-000001 | Mar 25, 2026 | — |
| 4 | 4 | 0001193125-26-120192 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120230 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120210 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120200 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120223 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120216 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120214 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120226 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120207 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120221 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120236 | Mar 23, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-120235 | Mar 23, 2026 | Mar 19, 2026 |
| 8-K | 8-K | 0001193125-26-117765 | Mar 20, 2026 | Mar 19, 2026 |
| 8-K | 8-K | 0001193125-26-110681 | Mar 17, 2026 | — |
| 10-K | 10-K | 0001193125-26-110693 | Mar 17, 2026 | Dec 31, 2025 |
| S-8 | S-8 | 0001193125-26-110791 | Mar 17, 2026 | — |
| SCHEDULE 13G | — | 0001831942-26-000014 | Mar 16, 2026 | — |
| SCHEDULE 13G | — | 0001213900-26-027660 | Mar 13, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-027730 | Mar 13, 2026 | — |
| 8-K | 8-K | 0001193125-26-099169 | Mar 10, 2026 | Mar 8, 2026 |
| 4 | 4 | 0001193125-26-094490 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | 4 | 0001193125-26-064089 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064103 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064105 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064141 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064151 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064174 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064166 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064069 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064176 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064059 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064061 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-063984 | Feb 23, 2026 | Feb 20, 2026 |
| 4 | 4 | 0001193125-26-064028 | Feb 23, 2026 | Feb 20, 2026 |
| SCHEDULE 13G | — | 0001596468-26-000004 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001193125-26-051535 | Feb 13, 2026 | — |
| 3 | 3 | 0001193125-26-036046 | Feb 3, 2026 | Jan 26, 2026 |
| 8-K | 8-K | 0001193125-26-029540 | Jan 29, 2026 | Jan 26, 2026 |
| 4 | 4 | 0001193125-26-013041 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-013038 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-013035 | Jan 14, 2026 | Jan 12, 2026 |
| 4 | 4 | 0001193125-26-006763 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006765 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006770 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006771 | Jan 7, 2026 | Jan 5, 2026 |
| SCHEDULE 13G | — | 0001596468-25-000022 | Nov 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-277662 | Nov 12, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-277673 | Nov 12, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-270255 | Nov 6, 2025 | Nov 4, 2025 |